Literature DB >> 14532905

Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats.

Yakup Aliciguzel1, Ikbal Ozen, Mutay Aslan, Umit Karayalcin.   

Abstract

Oxidative stress is an important pathogenic constituent in diabetic endothelial dysfunction. The aim of this study was to investigate whether an increase in oxidative stress related to xanthine oxidoreductase occurs in diabetes. Liver, brain, heart, and kidney xanthine oxidase (XO), xanthine dehydrogenase (XDH), antioxidant enzymes (glutathione peroxidase, superoxide dismutase, catalase), and nitrite levels were measured in control and early and late diabetic rat models. Although diabetes had no impact on liver XO and XDH activity, XDH activity in heart, kidney, and brain was significantly greater in late diabetic rats than in controls. Selenium glutathione peroxidase (GPx) activity was found to be lower in the liver, brain, kidney, and heart of late diabetic rats than in controls. The measured decrease in selenium GPx activity was also observed in early diabetic heart, kidney, and brain. No significant change was observed in liver, brain, and kidney copper/zinc superoxide dismutase (Cu/Zn SOD) activity in early and late diabetic rat models compared with that in controls, whereas heart Cu/Zn SOD activity was significantly decreased in both early and late diabetic rats. Liver and brain catalase activity remained similar among the different experimental groups, whereas increased heart and kidney catalase activity was observed in both early and late diabetic rats. Liver, kidney, and brain nitrite levels were found to be increased in early diabetic rat models compared with those in controls. These data suggest that the increased XDH and decreased selenium GPx activity observed in the later stages of diabetes leads to enhanced oxidative stress in the heart, kidney, and brain, resulting in secondary organ damage associated with the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532905     DOI: 10.1016/S0022-2143(03)00110-0

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  28 in total

1.  Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues.

Authors:  N Kamalakkannan; P Stanely Mainzen Prince
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

Review 2.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

3.  Quercitrin a bioflavonoid improves the antioxidant status in streptozotocin: induced diabetic rat tissues.

Authors:  Ranganathan Babujanarthanam; Purushothaman Kavitha; U S Mahadeva Rao; Moses Rajasekara Pandian
Journal:  Mol Cell Biochem       Date:  2011-06-29       Impact factor: 3.396

4.  Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes.

Authors:  Filiz Ozcan; Asli Ozmen; Bahar Akkaya; Yakup Aliciguzel; Mutay Aslan
Journal:  Clin Exp Med       Date:  2011-11-15       Impact factor: 3.984

Review 5.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

6.  Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats.

Authors:  Khalid S Al-Numair; Govindasamy Chandramohan; Chinnadurai Veeramani; Mohammed A Alsaif
Journal:  Redox Rep       Date:  2014-12-12       Impact factor: 4.412

7.  Literature-based discovery of diabetes- and ROS-related targets.

Authors:  Junguk Hur; Kelli A Sullivan; Adam D Schuyler; Yu Hong; Manjusha Pande; David J States; H V Jagadish; Eva L Feldman
Journal:  BMC Med Genomics       Date:  2010-10-27       Impact factor: 3.063

8.  Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats.

Authors:  Sefa Celik; Suat Erdogan
Journal:  Mol Cell Biochem       Date:  2008-02-12       Impact factor: 3.396

9.  Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabetic mice.

Authors:  Jeong-Ho Oak; Ji-Youn Youn; Hua Cai
Journal:  Cardiovasc Diabetol       Date:  2009-12-30       Impact factor: 9.951

10.  Increased Small Dense LDL and Decreased Paraoxonase Enzyme Activity Reveals Formation of an Atherogenic Risk in Streptozotocin-Induced Diabetic Guinea Pigs.

Authors:  Mutay Aslan; Filiz Ozcan; Ertan Kucuksayan
Journal:  J Diabetes Res       Date:  2013-03-27       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.